ARREVUS
Although there is a clear increase in bacteria “resistant” to standard therapies in a “test tube”, the real importance of resistance is when it becomes a clinical problem because of decreased effectiveness to treat serious life-threatening disease in patients by affecting clinical outcomes, such as mortality, decreased function and decreased quality of life for patients. For some diseases that are self-resolving and for which antibiotics aren’t required (e.g., sinusitis, bronchitis, o... titis media, skin abscesses), identification of antibiotic resistance remains a test tube phenomenon with little impact on patient outcomes. More concerning illnesses, such as serious disease due to methicillin-resistant S. aureus (MRSA), resistance may indeed result in decreased effectiveness for some older drugs but many therapies still remain and many new therapies currently exist to treat MRSA. Arrevus is focusing its drug development efforts on those diseases for which antibiotic resistance has important clinical implications and for which few therapies exist. These efforts are dedicated to the development of Designer Proline-rich Antimicrobial Peptide Chaperone Protein Inhibitors (“DPCs”)
ARREVUS
Industry:
Biotechnology Pharmaceutical
Founded:
2015-01-01
Address:
Raleigh, North Carolina, United States
Country:
United States
Website Url:
http://www.arrevus.com
Total Employee:
1+
Status:
Active
Total Funding:
2.05 M USD
Technology used in webpage:
SPF Microsoft Exchange Online Amazon Office 365 Mail Microsoft Azure DNS GoDaddy DNS Gravity Forms AWS Global Accelerator
Similar Organizations
Cyagen Biosciences
Cyagen Biosciences is an emerging and innovative biotechnology company.
Cyclerion Therapeutics
Cyclerion Therapeutics is a clinical-stage biopharmaceutical company.
Dizal Pharma
Dizal Pharma is a research-based biotechnology company.
Enterin
Philadelphia-based biotechnology company .
ExCellThera
ExCellThera is an advanced clinical stage biotechnology company.
Inversago Pharma
Inversago Pharma is a specialized, preclinical-stage biotech company.
KBP Biosciences
A multinational clinical stage biotechnology company.
Current Advisors List
Current Employees Featured
Founder
Investors List
U.S. Department of Defense
U.S. Department of Defense investment in Grant - Arrevus
North Carolina Biotechnology Center
North Carolina Biotechnology Center investment in Debt Financing - Arrevus
Official Site Inspections
http://www.arrevus.com
- Host name: 172.67.185.16
- IP address: 172.67.185.16
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
